| Associate Director, R&D Portfolio and Engagement - Communications |
Cambridge (Massachusetts) |
Etats-Unis |
Corporate Affairs |
CTS |
Communications & Public Affairs |
08 octobre 2024 |
| Associate Director, Finance and Strategy & Growth Activation Communications |
East Hanover |
Etats-Unis |
Corporate Affairs |
CTS |
Communications & Public Affairs |
08 octobre 2024 |
| Manager, Post Production & Video Services |
Hyderabad (Office) |
Inde |
Corporate Affairs |
CTS |
Communications & Public Affairs |
04 octobre 2024 |
| Communication & Patient Advocacy Manager (f/m/d) |
Vienna |
Autriche |
International |
CTS |
Communications & Public Affairs |
24 septembre 2024 |
| Manager, US Policy & Issues Communications |
East Hanover |
Etats-Unis |
Corporate Affairs |
CTS |
Communications & Public Affairs |
18 septembre 2024 |
| Public Affairs Manager |
Ankara Gimat |
Turquie |
International |
Innovative Medicines |
Communications & Public Affairs |
13 septembre 2024 |
| Manager, US Channel Operations & Publishing |
East Hanover |
Etats-Unis |
Corporate Affairs |
CTS |
Communications & Public Affairs |
05 septembre 2024 |
| EA & Program Coordinator |
Beijing (Beijing) |
Chine |
Corporate Affairs |
Innovative Medicines |
Communications & Public Affairs |
03 septembre 2024 |
| Patient Engagement Lead |
İstanbul Kavacık |
Turquie |
Corporate Affairs |
CTS |
Communications & Public Affairs |
03 septembre 2024 |
| Government Affairs Manager |
Moscow (City) |
Féd. de Russie |
Corporate Affairs |
Innovative Medicines |
Communications & Public Affairs |
29 juillet 2024 |
| Public Affairs Manager (m/f/d) |
Berlin West (Non-Sales Force) (Novartis Pharma GmbH) |
Allemagne |
International |
Innovative Medicines |
Communications & Public Affairs |
09 juillet 2024 |
| Executive Director, Public Affairs LaCan Region |
East Hanover |
Etats-Unis |
Corporate Affairs |
Corporate |
Communications & Public Affairs |
09 mai 2024 |
| Director, Public Affairs |
Shanghai (Shanghai) |
Chine |
People & Organization |
Innovative Medicines |
Communications & Public Affairs |
06 mai 2024 |